Details for Patent: 10,195,151

Which drugs does patent 10,195,151 protect, and when does it expire?

Patent 10,195,151 protects SUNOSI and is included in one NDA.

This patent has twenty patent family members in seventeen countries.

Summary for Patent: 10,195,151

Title:	Formulations of (R)-2-amino-3-phenylpropyl carbamate
Abstract:	The present invention relates to immediate release formulations of (R)-2-amino-3-phenylpropyl carbamate and methods of using the same to treat disorders.
Inventor(s):	Allphin; Clark Patrick (Seattle, WA), Walsh; Edwin Gerard (Dublin, IE)
Assignee:	Jazz Pharmaceuticals International III Limited (Hamilton, BM)
Application Number:	15/695,913
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,195,151
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Delivery; Dosage form;

Drugs Protected by US Patent 10,195,151

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Axsome Malta	SUNOSI	solriamfetol hydrochloride	TABLET;ORAL	211230-001	Jun 17, 2019		RX	Yes	No			Y
Axsome Malta	SUNOSI	solriamfetol hydrochloride	TABLET;ORAL	211230-002	Jun 17, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 10,195,151

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017324855
Canada	3036068
Chile	2019000571